Barrington Research Reiterates Buy Rating for Concentrix
Barrington Research reaffirms its buy stance on Concentrix with a $30 price target, a 33.90% upside from the current price.
Key Points
- Barrington Research reiterated its buy rating for Concentrix Corporation (CNXC) with a price target of $30 on June 30, 2026.
- Barrington Research's $30 price target implies 33.90% upside from Concentrix Corporation's ($CNXC) current $22.41 share price.
- Concentrix shares were trading at $25.23 on the NasdaqGS, with a market cap of $1.53 billion and a forward P/E ratio of 1.95.
- Recent insider activity includes Concentrix's CFO buying 2,500 shares on April 9, 2026, at an average price of $27.95.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Barrington Research reiterated its buy rating for Concentrix Corporation (NasdaqGS: CNXC), setting a price target of $30. This update came on June 30, 2026, as analyst Vincent Colicchio maintained his positive outlook on the company.
Concentrix Corporation Stock Down 23.7%
Shares of Concentrix Corporation traded near $25.23 on Tuesday. The company has a market cap of approximately $1.53 billion. It holds a forward P/E ratio of 1.95 and a beta of 0.423, indicating lower volatility compared to the market. The stock's 52-week range has been between $22.05 and $62.14, with a 50-day moving average of $25.86 and a 200-day moving average of $35.66. Concentrix also maintains a current ratio of 1.18 and a quick ratio of 0.88, with a debt-to-equity ratio of 204.04.
$CNXC price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
Concentrix reported revenues of $9.95 billion, reflecting a modest growth of 5.4%. However, the company is not currently profitable, with a net margin of -13.34% and a return on equity of -38.92%. The company announced its next earnings report would be on June 29, 2026.
Insider Buying and Selling at Concentrix Corporation
In recent insider activity, Concentrix's Chief Financial Officer, Valentine Andre, purchased 2,500 shares on April 9, 2026, at an average price of $27.95. Additionally, President and CEO Christopher Caldwell bought 1,000 shares on March 26, 2026, at $26.97 each. Several other insiders, including Laverne Council, Jennifer Deason, and Kathryn Hayley, acquired 7,701 shares each on March 25, 2026.
Analysts Set New Price Targets
On June 30, 2026, Barrington Research maintained its buy rating with a $30 price target for Concentrix. Baird also maintained a buy rating, setting the same $30 target. The consensus among analysts is a buy recommendation, with a mean price target of $41.25 based on inputs from four analysts.
About Concentrix Corporation
Concentrix Corporation, headquartered in Newark, California, specializes in designing and operating integrated customer experience solutions. The company offers a range of services, including process optimization, technology innovation, and analytics, across various sectors such as technology, retail, and healthcare. Led by CEO Christopher Caldwell, Concentrix employs around 455,000 people globally.
Bottom Line
Barrington Research's reiteration of a buy rating for Concentrix highlights continued confidence in the company's potential, despite its current challenges with profitability. Investors often track such analyst updates for insights into market sentiment. It's important to remember that analyst ratings are forward-looking and can influence stock performance, but they are not guarantees of future results.
Get Concentrix Corporation alerts
New 13F filings, insider trades, and analyst moves on $CNXC, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.